Cite
Cetin V, Piperdi B, Bathini V, et al. A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma. Gastrointest Cancer Res. 2013;6(4):S2-9
Cetin, V., Piperdi, B., Bathini, V., Walsh, W. V., Yunus, S., Tseng, J. F., Whalen, G. F., Wassef, W. Y., Kadish, S. P., Fitzgerald, T. J., Mikule, C., Wang, Y., & Grossman, S. R. (2013). A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma. Gastrointestinal cancer research : GCR, 6(4), S2-9.
Cetin, Volkan, et al. "A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma." Gastrointestinal cancer research : GCR vol. 6,4 (2013): S2-9.
Cetin V, Piperdi B, Bathini V, Walsh WV, Yunus S, Tseng JF, Whalen GF, Wassef WY, Kadish SP, Fitzgerald TJ, Mikule C, Wang Y, Grossman SR. A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma. Gastrointest Cancer Res. 2013 Jul;6(4):S2-9. PMID: 24312684; PMCID: PMC3849911.
Copy
Download .nbib